People with diabetes lost up to 34 pounds taking Eli Lilly drug, company says

helped obese patients with Type 2 diabetes lose 15% of their body weight, or about 34 pounds, on average, in a late-stage clinical trial, the drugmaker said in a news release Thursday.— which is sold under the brand name Mounjaro for Type 2 diabetes — can be used as an effective weight loss aid.found that tirzepatide helped patients without Type 2 diabetes lose 22.5% of their body weight on average, or about 52 pounds. Patients in that trial had obesity or were overweight.

The participants in the trial received a weekly injection of tirzepatide or a placebo for 72 weeks. Two doses of tirzepatide were studied: a 10-milligram dose and a 15 mg dose. Thursday’s results were announced in a news release and haven’t been made available for peer review yet., said Dr. Susan Spratt, an endocrinologist and senior medical director for the Population Health Management Office at Duke Health in North Carolina.

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Eli Lilly stock up premarket as company’s Q1 revenue beats and it raises guidanceEli Lilly & Co. shares rose 2% premarket Thursday, after the company posted first-quarter earnings showing a revenue beat and raised its full-year guidance....
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »

Popular diabetes drug Mounjaro could be FDA-approved for weight loss this year, company saysA popular drug currently approved to treat Type 2 diabetes could soon also be approved for weight loss.
Herkunft: ABC - 🏆 471. / 51 Weiterlesen »